ZYDEX
BEIT JALA COMPANY
Identification
- Active ingredient (INN)
- ACIDE FUSIDIQUE
- Internal code
- 17 D 104
- Country of Origin
- Palestine
- Pharmaceutical form
- Ophthalmic Gel
- Prescription List
- Highly Regulated (List I)
- Packaging
- t/5g
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] An antibiotic isolated from the fermentation broth of Fusidium coccineum. (From Merck Index, 11th ed) It acts by inhibiting translocation during protein synthesis. 0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] It is often used topically in creams and eyedrops but is available in systemic formulations including tablets and injections.
Indications
0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] For the treatment of bacterial infections. 0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)]
Associated Conditions
0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE).
Pharmacodynamics
0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] Fusidic acid is a bacteriostatic antibiotic and helps prevent bacterial growth while the immune system clears the infection.
Absorption
0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] Sodium fusidic acid tablets have a 91% oral bioavailability. 0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] Absorption of the film-coated tablets is complete when compared to a solution, however oral absorption is variable. 0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] Oral fusidic acid hemihydrate (suspension) achieved a 22.5% bioavailability in pediatric patients following a 20 milligram/kilogram dose.
Metabolism
0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] Metabolites include dicarboxylic ester/acid, 3-keto fusidic acid, hydroxy fusidic acid, glucuronide fusidic acid and a glycol metabolite. 0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] Hover over products below to view reaction partners Fusidic acid Malonic acid 3-keto fusidic acid Dicarboxylic ester Glucuronide fusidic acid Hydroxy fusidic acid.
Half-life
0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] Approximately 5-6 hours in adults.
Adverse Effects
0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. 0,13 % COLLYRE SOL RÉCIP UNIDOSE (LACRIFLUID UNIDOSE)] View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.
Warnings
For external use only.
Do not use more than one acne product at a time.
Dosage & Administration
After area is wet with
Blemfree™ Cleansing Wash Concentrate has foamed, tap Blemfree™ Cleansing Spheres with fingertips and massage in small circles for 60 seconds.
Proceed to rinse step.